Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Journal of Hepatology|July 25, 2000
Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3L Rubbia-Brandt, R Quadri, K Abid, et al.
Journal of Hepatology|April 16, 1998
Characteristics of patients with dual infection by hepatitis B and C virusesJ P Zarski, B Bohn, A Bastie, et al.
Gastrointestinal Endoscopy|July 30, 1999
Effectiveness of a manual disinfection procedure in eliminating hepatitis C virus from experimentally contaminated endoscopesB Chanzy, D L Duc-Bin, B Rousset, et al.
Hepatology (Baltimore, Md.)|December 22, 2000
Hepatitis B virus Dane particles bind to human plasma apolipoprotein HI Stefas, M Rucheton, A D D'Angeac, et al.
Annales De Chirurgie|July 20, 2000
[Liver transplantation with a graft taken from a heart transplant patient who was brain-dead]C Arvieux, C Létoublon, F Bouchard, et al.
Hepatology (Baltimore, Md.)|November 26, 1998
Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc)J L Payen, J Izopet, V Galindo-Migeot, et al.
Journal of Viral Hepatitis|June 20, 2007
Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infectionD Roulot, V Bourcier, V Grando, et al.
Journal of Viral Hepatitis|December 17, 2013
Predictors associated with treatment initiation and switch in a real-world chronic hepatitis B population from five European countriesH Leblebicioglu, V Arama, X Causse, et al.
Journal of Hepatology|July 16, 1999
Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival. Multi-centre groupT Poynard, S Naveau, M Doffoel, et al.
Alimentary Pharmacology & Therapeutics|August 16, 2006
Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective studyC Bonny, H Fontaine, T Poynard, et al.
Pageof 8